Literature DB >> 10648927

Phage antibodies against human dendritic cell subpopulations obtained by flow cytometry-based selection on freshly isolated cells.

A Lekkerkerker1, T Logtenberg.   

Abstract

In one application of phage display technology, large libraries of antibody fragments displayed on phage particles are used to select antibodies that bind to molecules expressed on the surface of eukaryotic cells. The advantage of this method is that antibodies can be selected against antigens in their native configuration, without the need to purify or express the antigen as a recombinant protein. Moreover, this approach may be used to search for novel membrane molecules expressed by subpopulations of cells that are difficult to address by conventional methods, e.g., small numbers of cells present in heterogeneous mixtures. It has been shown that the isolation of cell-bound phages is compatible with immunofluorescence staining and flow cytometric identification and sorting of cells based on multiparameter analysis. Here, we have employed a semi-synthetic phage display library of human single-chain Fv (scFv) antibody fragments in combination with flow cytometry to isolate antibodies against rare populations of precursor and mature dendritic cells (DCs) present in human peripheral blood. DCs are a phenotypically heterogeneous population of professional antigen presenting cells of bone marrow origin with complex and only partly understood developmental relationships and functions. We have isolated phage antibodies against subpopulations of blood DCs and analyzed the distribution of the target antigens. The results show that these phage antibodies are useful tools to further dissect relationships and function of DCs in healthy and diseased tissues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10648927     DOI: 10.1016/s0022-1759(99)00140-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Preparation of single chain variable fragment of MG(7) mAb by phage display technology.

Authors:  Z C Yu; J Ding; Y Z Nie; D M Fan; X Y Zhang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Expression and bioactivity identification of soluble MG7 scFv.

Authors:  Zhao-Cai Yu; Jie Ding; Bo-Rong Pan; Dai-Ming Fan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

3.  An entirely cell-based system to generate single-chain antibodies against cell surface receptors.

Authors:  Barbara D Lipes; Yu-Hsun Chen; Hongzheng Ma; Herman F Staats; Daniel J Kenan; Michael Dee Gunn
Journal:  J Mol Biol       Date:  2008-04-07       Impact factor: 5.469

4.  Use of real-time polymerase chain reaction to identify cell- and tissue-type-selective peptides by phage display.

Authors:  David L Jaye; Frederick S Nolte; Luca Mazzucchelli; Cissy Geigerman; Adil Akyildiz; Charles A Parkos
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

Review 5.  Bacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infection.

Authors:  Babak Bakhshinejad; Majid Sadeghizadeh
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 6.  scFv antibody: principles and clinical application.

Authors:  Zuhaida Asra Ahmad; Swee Keong Yeap; Abdul Manaf Ali; Wan Yong Ho; Noorjahan Banu Mohamed Alitheen; Muhajir Hamid
Journal:  Clin Dev Immunol       Date:  2012-03-15

7.  A novel assay for monitoring internalization of nanocarrier coupled antibodies.

Authors:  Ulrik B Nielsen; Dmitri B Kirpotin; Edward M Pickering; Daryl C Drummond; James D Marks
Journal:  BMC Immunol       Date:  2006-10-02       Impact factor: 3.615

8.  A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries.

Authors:  Katja Klausz; Michael Cieker; Christian Kellner; Hans-Heinrich Oberg; Dieter Kabelitz; Thomas Valerius; Renate Burger; Martin Gramatzki; Matthias Peipp
Journal:  Oncotarget       Date:  2017-09-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.